Fibroid volume (cm³) · women with uterine fibroids
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Uterine size (cm3) ‐ · women with uterine fibroids
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Pain up to 1 month after treatment VAS2 · patients with fibromyalgia
1 finding from 1 review
Physical function · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Global well‐being: rated by participants · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Sleep · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Fatigue · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Stiffness · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · patients with fibromyalgia
1 finding from 1 review
Depressive disorder according to DSM or ICD criteriaClinician diagnostic interview · patients with depressive disorders in children and adolescents
1 finding from 1 review
Suicide completionCompleted suicide rates · patients with depressive disorders in children and adolescents
1 finding from 1 review
Remission or response (as defined in trial) · patients with depressive disorders in children and adolescents
Second generation antidepressant probably leads to higher remission or response (as defined in trial) compared with placebo (by medication) (moderate certainty).
1 finding from 1 review
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with depressive disorders in children and adolescents
Second generation antidepressant may leads to higher suicide‐related outcome compared with placebo (by medication) (low certainty).
1 finding from 1 review
Depressive symptoms · patients with depressive disorders in children and adolescents
1 finding from 1 review
symptom severity (dichotomous outcome) Dichotomous measure of overall symptom severity1 · people with irritable bowel syndrome
Acupuncture may leads to higher symptom severity (dichotomous outcome) Dichotomous measure of… compared with pharmaceutical medications (low certainty).
1 finding from 1 review
Suicide · patients with schizophrenia and severe mental illness
INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY showed no clear difference in committed suicide by three years compared with MEDICATION (low certainty).
1 finding from 1 review
Global impression: 1. Not able to be discharged (long term) · patients with schizophrenia and severe mental illness
INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY may leads to higher global impression: 1. Not able to be discharged (long term) compared with MEDICATION (low certainty).
1 finding from 1 review
All symptomatic CMV disease · solid organ transplant recipients
Antiviral prophylaxis leads to lower CMV disease: all symptomatic CMV disease compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death associated with CMV disease · solid organ transplant recipients
Ganciclovir showed no clear difference in death due to CMV disease compared with aciclovir (moderate certainty).
1 finding from 1 review
All‐cause death · solid organ transplant recipients
Ganciclovir showed no clear difference in all‐cause death compared with aciclovir (moderate certainty).
1 finding from 1 review